Photo: Pexels

COVID-19 latest: SA reports 6 787 new reported cases, 199 deaths

The Health Department has said on Monday that the cumulative number of recoveries now stands at 2 308 054 with a recovery rate of 90.9%.


Photo: Pexels

South Africa recorded 6 787 new cases of COVID-19 in the last 24 hours, the National Institute for Communicable Diseases (NICD) has said on Monday. 


This brings the total number of laboratory-confirmed cases to 2 540 222. 

This increase of 6 787 new COVID-19 cases represents a 21.7 % positivity rate. 

A further 199 COVID-19 related deaths have been reported, bringing total fatalities to 75 012 to date.

“The cumulative number of recoveries is 2 308 054.” 

ALSO READ: Covid-19 kills anti-vaxxer family in UK: Son loses father, mother, brother

A total of 241 hospital admissions has been reported in the past 24 hours.

The Western Cape province is still in the lead with the majority of new cases: 1 967 (29%), followed by KwaZulu-Natal with 1 442 new cases (21%) and Gauteng with 1 039 new cases (15%) provinces. 

For more detailed information, visit the GIS Dashboard.

15 257 317 tests have been conducted in both public and private sectors.

There’s some good news on the vaccine front: The Sisonke Implementation Study has found that the Johnson & Johnson COVID-19 vaccine is effective against the Delta variant, which accounted for South Africa’s third wave and spread quite rapidly.

The results of the study were presented by its co-principal lead Professor Glenda Gray, on Friday, 6 August 2021. Gray said the findings indicate that there is great protection against COVID-19 hospitalisation and death.

“Protection is good against both the Beta and the Delta variant. There was 67% protection against hospitalisation with the Beta variant and 71% protection against hospitalisation with the Delta variant,” she said.

Gray said their data shows that there is better efficacy against Delta than there is against the Beta.

More than 477 000 healthcare workers were administered the J&J vaccine at the start of the trial back in February.

ALSO READ: Vaccine latest: J&J EFFECTIVE against Delta variant, study finds